Stock listing
Engene Therapeutics Inc.
Selected listing: ENGN · NASDAQ · USD · US
Engene Therapeutics Inc. (NASDAQ:ENGN), Commercial Services. Latest release Sep 8, 2026: enGene Reports Third Quarter 2026 Financial Results and Provides…
- Ticker
- NASDAQ:ENGN
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
About Engene Therapeutics Inc.
Engene Therapeutics Inc. is a public company traded under the ticker ENGN in the American market. Engene focuses on developing innovative therapeutics, leveraging advanced technologies to address unmet medical needs.
Latest news from Engene Therapeutics Inc.
enGene Reports Third Quarter 2026 Financial Results and Provides Business Update
September 8, 2026
enGene Focuses Board to Support Planned Upcoming Regulatory and Commercial Milestones
July 16, 2026
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
June 15, 2026
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
May 7, 2026
enGene Announces Name Change to enGene Therapeutics Inc.
April 6, 2026
Research Engene Therapeutics Inc.
Engene Therapeutics Inc. company profile
View the public company page for Engene Therapeutics Inc. on 6ix.
Engene Therapeutics Inc. news
Read company news and market updates connected to Engene Therapeutics Inc..
Engene Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Engene Therapeutics Inc..